Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.

David Simon, Koray Tascilar, Filippo Fagni, Arnd Kleyer, Gerhard Krönke, Christine Meder, Peter Dietrich, Till Orlemann, Johanna Mößner, Jule Taubmann, Melek Yalcin Mutlu, Johannes Knitza, Stephan Kemenes, Anna-Maria Liphardt, Verena Schönau, Daniela Bohr, Louis Schuster, Fabian Hartmann, Ioanna Minopoulou, Moritz LeppkesAndreas Ramming, Milena Pachowsky, Florian Schuch, Monika Ronneberger, Stefan Kleinert, Axel Hueber (Co-author), Karin Manger, Bernhard Manger, Raja Atreya, Carola Berking, Michael Sticherling, Markus F Neurath, Georg Schett

    Research output: Contribution to journalOriginal Articlepeer-review

    12 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)e614-e625
    JournalLANCET RHEUMATOLOGY
    Volume4
    Issue number9
    DOIs
    Publication statusPublished - 2022

    Keywords

    • COVID-19 VACCINATION
    • INDIVIDUALS
    • OUTCOMES

    Cite this